Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Cetuximab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CORAL
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 17 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 18 Jan 2014 Interim results presented at the 2014 Gastrointestinal Cancers Symposium.